_id
69130a46ccc777a4e85d7c0e
Ticker
KLDO
Name
Kaleido Biosciences Inc
Exchange
PINK
Address
65 Hayden Avenue, Lexington, MA, United States, 02421
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://kaleido.com
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Last Close
0.0001
Volume
49945
Current Price
0.0001
Change
0
Last Updated
2025-12-01T09:55:31.116Z
Image
-
Ipo Date
2019-02-28T00:00:00.000Z
Market Cap
4262
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.5
Target Price
22
Strong Buy
2
Buy
2
Hold
0
Sell
1
Strong Sell
1
Current Quarter
2023-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
42622559
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Depreciation
-39586
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
PE
-
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
45
Deep Value Investing Score
0
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
0
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
41859993
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-39586
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
41859993
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
122085
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
41859993
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
41584
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
41859993
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > cash Flow > net Income
-
Quarters > 3 > cash Flow > depreciation
54880
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
-
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
41859993
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
228485
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
45
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
1104000
Annuals > 1 > income Statement > cost Of Revenue
2358000
Annuals > 1 > income Statement > gross Profit
-1254000
Annuals > 1 > income Statement > operating Expenses
86413000
Annuals > 1 > income Statement > operating Income
-87667000
Annuals > 1 > income Statement > interest Expense
2838000
Annuals > 1 > income Statement > pretax Income
-90288000
Annuals > 1 > income Statement > net Income
-90288000
Annuals > 1 > income Statement > eps
-2.15690432628596
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
41859993
Annuals > 1 > income Statement > income Tax Expense
2983000
Annuals > 1 > income Statement > EBITDA
-85092000
Annuals > 1 > income Statement > operating Margin
-7940.851449275362
Annuals > 1 > income Statement > total Other Income Expense Net
-2621000
Annuals > 1 > balance Sheet > cash
38474000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
934000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
42311000
Annuals > 1 > balance Sheet > property Plant Equipment
5665000
Annuals > 1 > balance Sheet > total Assets
50137000
Annuals > 1 > balance Sheet > payables
5670000
Annuals > 1 > balance Sheet > short Term Debt
16144000
Annuals > 1 > balance Sheet > long Term Debt
5550000
Annuals > 1 > balance Sheet > total Liabilities
39530000
Annuals > 1 > balance Sheet > equity
10607000
Annuals > 1 > cash Flow > net Income
-90288000
Annuals > 1 > cash Flow > depreciation
2358000
Annuals > 1 > cash Flow > change In Working Capital
-263000
Annuals > 1 > cash Flow > cash From Operations
-77094000
Annuals > 1 > cash Flow > capital Expenditures
1129000
Annuals > 1 > cash Flow > cash From Investing
-691000
Annuals > 1 > cash Flow > cash From Financing
70037000
Annuals > 1 > cash Flow > net Change In Cash
-7748000
Annuals > 1 > ratios > PE
-2.15690432628596
Annuals > 1 > ratios > PB
0.00039464497973036675
Annuals > 1 > ratios > ROE
-851.211464127463
Annuals > 1 > ratios > ROA
-180.08257374793067
Annuals > 1 > ratios > FCF
-78223000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-70.85416666666667
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
975000
Annuals > 2 > income Statement > cost Of Revenue
55967
Annuals > 2 > income Statement > gross Profit
975000
Annuals > 2 > income Statement > operating Expenses
79849000
Annuals > 2 > income Statement > operating Income
-78874000
Annuals > 2 > income Statement > interest Expense
2802000
Annuals > 2 > income Statement > pretax Income
-81619000
Annuals > 2 > income Statement > net Income
-79796000
Annuals > 2 > income Statement > eps
-2.3855155237880106
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
33450212
Annuals > 2 > income Statement > income Tax Expense
-1823000
Annuals > 2 > income Statement > EBITDA
-77051000
Annuals > 2 > income Statement > operating Margin
-8089.641025641026
Annuals > 2 > income Statement > total Other Income Expense Net
-2745000
Annuals > 2 > balance Sheet > cash
46222000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
48721000
Annuals > 2 > balance Sheet > property Plant Equipment
8462000
Annuals > 2 > balance Sheet > total Assets
59344000
Annuals > 2 > balance Sheet > payables
5389000
Annuals > 2 > balance Sheet > short Term Debt
2634000
Annuals > 2 > balance Sheet > long Term Debt
18375000
Annuals > 2 > balance Sheet > total Liabilities
38848000
Annuals > 2 > balance Sheet > equity
20496000
Annuals > 2 > cash Flow > net Income
-81620000
Annuals > 2 > cash Flow > depreciation
1823000
Annuals > 2 > cash Flow > change In Working Capital
4551000
Annuals > 2 > cash Flow > cash From Operations
-61518000
Annuals > 2 > cash Flow > capital Expenditures
4024000
Annuals > 2 > cash Flow > cash From Investing
-4024000
Annuals > 2 > cash Flow > cash From Financing
40399000
Annuals > 2 > cash Flow > net Change In Cash
-25143000
Annuals > 2 > ratios > PE
-2.3855155237880106
Annuals > 2 > ratios > PB
0.00016320361046057768
Annuals > 2 > ratios > ROE
-389.3247462919594
Annuals > 2 > ratios > ROA
-134.46346724184417
Annuals > 2 > ratios > FCF
-65542000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-67.2225641025641
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1318000
Annuals > 3 > income Statement > gross Profit
-1318000
Annuals > 3 > income Statement > operating Expenses
86660000
Annuals > 3 > income Statement > operating Income
-86660000
Annuals > 3 > income Statement > interest Expense
977000
Annuals > 3 > income Statement > pretax Income
-86331000
Annuals > 3 > income Statement > net Income
-85013000
Annuals > 3 > income Statement > eps
-3.3074781266149453
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25703269
Annuals > 3 > income Statement > income Tax Expense
-1318000
Annuals > 3 > income Statement > EBITDA
-85342000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
329000
Annuals > 3 > balance Sheet > cash
71241000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
73279000
Annuals > 3 > balance Sheet > property Plant Equipment
6742000
Annuals > 3 > balance Sheet > total Assets
82306000
Annuals > 3 > balance Sheet > payables
2016000
Annuals > 3 > balance Sheet > short Term Debt
68000
Annuals > 3 > balance Sheet > long Term Debt
20391000
Annuals > 3 > balance Sheet > total Liabilities
33423000
Annuals > 3 > balance Sheet > equity
48883000
Annuals > 3 > cash Flow > net Income
-86331000
Annuals > 3 > cash Flow > depreciation
1318000
Annuals > 3 > cash Flow > change In Working Capital
-1216000
Annuals > 3 > cash Flow > cash From Operations
-75796000
Annuals > 3 > cash Flow > capital Expenditures
3586000
Annuals > 3 > cash Flow > cash From Investing
-3586000
Annuals > 3 > cash Flow > cash From Financing
74642000
Annuals > 3 > cash Flow > net Change In Cash
-4740000
Annuals > 3 > ratios > PE
-3.3074781266149453
Annuals > 3 > ratios > PB
0.000052581202053883767
Annuals > 3 > ratios > ROE
-173.91117566434139
Annuals > 3 > ratios > ROA
-103.2889461278643
Annuals > 3 > ratios > FCF
-79382000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2025-12-14T00:44:06.424Z
Earnings History > 0 > period
2022-06-30
Earnings History > 0 > report Date
2022-08-10
Earnings History > 0 > date
2022-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.25
Earnings History > 0 > eps Difference
0.25
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2022-03-31
Earnings History > 1 > report Date
2022-04-01
Earnings History > 1 > date
2022-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.47
Earnings History > 1 > eps Estimate
-0.58
Earnings History > 1 > eps Difference
0.11
Earnings History > 1 > surprise Percent
18.9655
Earnings History > 2 > period
2021-12-31
Earnings History > 2 > report Date
2022-03-29
Earnings History > 2 > date
2021-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.48
Earnings History > 2 > eps Estimate
-0.59
Earnings History > 2 > eps Difference
0.11
Earnings History > 2 > surprise Percent
18.6441
Earnings History > 3 > period
2021-09-30
Earnings History > 3 > report Date
2021-11-01
Earnings History > 3 > date
2021-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.54
Earnings History > 3 > eps Estimate
-0.54
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
0
Earnings History > 4 > period
2021-06-30
Earnings History > 4 > report Date
2021-08-11
Earnings History > 4 > date
2021-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.56
Earnings History > 4 > eps Estimate
-0.57
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
1.7544
Earnings History > 5 > period
2021-03-31
Earnings History > 5 > report Date
2021-05-04
Earnings History > 5 > date
2021-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.58
Earnings History > 5 > eps Estimate
-0.59
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
1.6949
Earnings History > 6 > period
2020-12-31
Earnings History > 6 > report Date
2021-03-03
Earnings History > 6 > date
2020-12-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.56
Earnings History > 6 > eps Estimate
-0.4
Earnings History > 6 > eps Difference
-0.16
Earnings History > 6 > surprise Percent
-40
Earnings History > 7 > period
2020-09-30
Earnings History > 7 > report Date
2020-11-02
Earnings History > 7 > date
2020-09-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.65
Earnings History > 7 > eps Estimate
-0.63
Earnings History > 7 > eps Difference
-0.02
Earnings History > 7 > surprise Percent
-3.1746
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-08-04
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.59
Earnings History > 8 > eps Estimate
-0.59
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2020-03-31
Earnings History > 9 > report Date
2020-05-14
Earnings History > 9 > date
2020-03-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.64
Earnings History > 9 > eps Estimate
-0.64
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2019-12-31
Earnings History > 10 > report Date
2020-03-02
Earnings History > 10 > date
2019-12-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.61
Earnings History > 10 > eps Estimate
-0.34
Earnings History > 10 > eps Difference
-0.27
Earnings History > 10 > surprise Percent
-79.4118
Earnings History > 11 > period
2019-09-30
Earnings History > 11 > report Date
2019-10-30
Earnings History > 11 > date
2019-09-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.74
Earnings History > 11 > eps Estimate
-0.89
Earnings History > 11 > eps Difference
0.15
Earnings History > 11 > surprise Percent
16.8539
Earnings History > 12 > period
2019-06-30
Earnings History > 12 > report Date
2019-08-01
Earnings History > 12 > date
2019-06-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.83
Earnings History > 12 > eps Estimate
-0.71
Earnings History > 12 > eps Difference
-0.12
Earnings History > 12 > surprise Percent
-16.9014
Earnings History > 13 > period
2019-03-31
Earnings History > 13 > report Date
2019-05-02
Earnings History > 13 > date
2019-03-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.56
Earnings History > 13 > eps Estimate
-0.67
Earnings History > 13 > eps Difference
-0.89
Earnings History > 13 > surprise Percent
-132.8358
Earnings History > 14 > period
2018-12-31
Earnings History > 14 > report Date
2019-03-01
Earnings History > 14 > date
2018-12-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.23
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.23
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-06-30
Earnings History > 15 > report Date
2018-09-25
Earnings History > 15 > date
2018-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.79
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.79
Earnings History > 15 > surprise Percent
-
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AStockWatch: Kaleido Shares Crater as Company Ceases Operations Genetic Engineering and Biotechnology News
Read more →Showing 2 of 6
(Last Updated 2023-09-30)
Rating:
BUY
Target Price:
$22
Analyst Picks
Strong Buy
2
Buy
2
Hold
0
Sell
1
Strong Sell
1
(Last Updated 2023-09-30)
Health Score
* Institutions hold a combined 1.80% of the total shares of Kaleido Biosciences Inc
1.
Artal Group S A(1.1743%)
since
2022/06/30
2.
State St US Sm Cap Enhanced SL Cl I(0.2501%)
since
2022/09/30
3.
Fidelity® Select Biotechnology(0.1991%)
since
2022/09/30
4.
iShares Russell 2000 Small-Cap Idx Instl(0.045%)
since
2022/03/31
5.
Northern Small Cap Core K(0.0334%)
since
2022/09/30
6.
Xtrackers Russell 2000 ETF 1C(0.0244%)
since
2022/09/30
7.
NT Quality Small Cap Core(0.0219%)
since
2022/09/30
8.
NT Quality SCC US Fund - L(0.0219%)
since
2022/09/30
9.
The Vanguard Total Stock Market Index(0.0106%)
since
2022/02/28
10.
BlackRock Small Cap Index V.I. I(0.0075%)
since
2022/03/31
11.
MM Russell 2000® Small Cap Index I(0.0043%)
since
2022/03/31
12.
iShares Russell Small/Mid-Cap Idx K(0.0034%)
since
2022/03/31
13.
Close Asset Management Limited(0.0002%)
since
2022/06/30
14.
Rydex Russell 2000 2x Strategy A(0.0002%)
since
2022/03/31
15.
Rydex Russell 2000 1.5x Strategy H(0.0001%)
since
2022/03/31
16.
CapTrust Financial Advisors(0%)
since
2022/06/30
17.
State Street Corporation(0%)
since
2022/06/30
18.
Palo Alto Investors, LLC(0%)
since
2022/06/30
19.
Wells Fargo & Co(0%)
since
2022/06/30
20.
Northern Trust Corp(0%)
since
2022/06/30
21.
Federated Hermes Inc(0%)
since
2022/06/30
22.
State Of Wisconsin Investment Board(0%)
since
2022/06/30
23.
Barclays PLC(0%)
since
2022/06/30
24.
Citadel Advisors Llc(0%)
since
2022/06/30
25.
Millennium Management LLC(0%)
since
2022/06/30
26.
Harbourvest Partners, LLC(0%)
since
2022/06/30
27.
BNP Paribas Arbitrage, SA(0%)
since
2022/06/30
28.
U.S. Bancorp(0%)
since
2022/06/30
29.
Amalgamated Financial Corp(0%)
since
2022/06/30
30.
State Board Of Admin Of Florida Retir(0%)
since
2022/06/30
31.
Endurance Wealth Management, Inc.(0%)
since
2022/06/30
32.
American International Group Inc(0%)
since
2022/06/30
33.
New York State Common Retirement Fund(0%)
since
2022/06/30
34.
Rydex Var Russell 2000® 1.5x Strategy(0%)
since
2022/03/31
35.
Rydex Var Russell 2000® 2x Strategy(0%)
since
2022/03/31
36.
BlackRock LifePath Idx Cons 2065 Fund F(0%)
since
2022/02/28
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2022-06-30
EPS Actual
0
EPS Estimate
-0.25
EPS Difference
0.25
Surprise Percent
100%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.